Literature DB >> 30747146

Introduction History of rabies control by vaccination.

A C Banyard, L M McElhinney, N Johnson, A R Fooks.   

Abstract

Since antiquity, rabies has remained one of the deadliest infectious diseases known to humankind, with a case fatality rate approaching 100% following the onset of clinical disease. It is present on all continents where terrestrial mammals exist, with the majority of animal and human cases being reported in the resourcelimited countries of Africa and Asia, with thousands of human rabies deaths being recorded annually. It is likely, however, that the global figure of approximately 59,000 annual human rabies fatalities is an underestimate. The impact of the disease has been reduced substantially across vast regions of the globe since the development of effective rabies vaccines. The success of different vaccines and vaccination policies in the defined 'at risk' populations has been born out of scientific innovation. Mass vaccination campaigns of animals, using parenteral vaccines to immunise companion animals, and advances in oral vaccines for wildlife, have allowed the elimination of rabies in terrestrial carnivores in several regions worldwide, including Western Europe and much of North America. In addition, human vaccines, largely used for post-exposure treatments, have reduced the burden of rabies in endemic areas.

Entities:  

Keywords:  Control; Dog; Elimination history; Immunity; Rabies; Vaccine; Wildlife

Mesh:

Substances:

Year:  2018        PMID: 30747146     DOI: 10.20506/rst.37.2.2804

Source DB:  PubMed          Journal:  Rev Sci Tech        ISSN: 0253-1933            Impact factor:   1.181


  3 in total

1.  Modelling the factors affecting the probability for local rabies elimination by strategic control.

Authors:  Johann L Kotzé; John Duncan Grewar; Aaron Anderson
Journal:  PLoS Negl Trop Dis       Date:  2021-03-04

2.  Immunogenicity and safety of human diploid cell vaccine (HDCV) vs. purified Vero cell vaccine (PVRV) vs. purified chick embryo cell vaccine (PCECV) used in post-exposure prophylaxis: a systematic review and meta-analysis.

Authors:  Shi-Yuan Wang; Jin-Fang Sun; Pei Liu; Li Luo; Jing-Xin Li; Feng-Cai Zhu; Xu-Xiang Shen; Fan-Yue Meng
Journal:  Hum Vaccin Immunother       Date:  2022-02-22       Impact factor: 3.452

Review 3.  [New aspects of rabies control].

Authors:  H Bourhy; G D de Melo; A Tarantola
Journal:  Bull Acad Natl Med       Date:  2020-09-18       Impact factor: 0.144

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.